about
Efficient directional cloning of recombinant adenovirus vectors using DNA-protein complexHelper T cell epitope-mapping reveals MHC-peptide binding affinities that correlate with T helper cell responses to pneumococcal surface protein A.Anthrax toxin-mediated delivery in vivo and in vitro of a cytotoxic T-lymphocyte epitope from ovalbuminTransduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers.Modulation of viral immunoinflammatory responses with cytokine DNA administered by different routesInduction of influenza-specific mucosal immunity by an attenuated recombinant Sendai virus.Vaccination strategies for mucosal immune responsesExisting antilisterial immunity does not inhibit the development of a Listeria monocytogenes-specific primary cytotoxic T-lymphocyte response.In silico prediction of peptides binding to multiple HLA-DR molecules accurately identifies immunodominant epitopes from gp43 of Paracoccidioides brasiliensis frequently recognized in primary peripheral blood mononuclear cell responses from sensitizMonitoring of peptide-specific and gamma interferon-productive T cells in patients with active and convalescent tuberculosis using an enzyme-linked immunosorbent spot assay.Single intranasal immunization with recombinant adenovirus-based vaccine induces protective immunity against respiratory syncytial virus infectionTransduction of dendritic cells with recombinant adenovirus encoding HCA661 activates autologous cytotoxic T lymphocytes to target hepatoma cellsDengue Vaccine: The Current StatusExpression and characterization of bovine lactoperoxidase by recombinant vaccinia virusDNA immunization of neonates induces immunity despite the presence of maternal antibody.New insights on adenovirus as vaccine vectors.Marked enhancement of the antigen-specific immune response by combining plasmid DNA-based immunization with a Schiff base-forming drugProtective efficacy of a DNA influenza virus vaccine is markedly increased by the coadministration of a Schiff base-forming drug.Type I interferon gene therapy protects against cytomegalovirus-induced myocarditis.
P2860
Q32082734-EFD6AE1A-27D3-46E3-B9DF-E216A739EBE0Q33535951-A7EE1EF1-8240-4C91-B5CC-A27B5F643039Q33750314-C1F75257-165C-44CA-BE8D-12AD62E39B6CQ33782809-231D57DA-1208-46F0-8348-25F540281F98Q33784988-1A74A57E-A28A-4E4A-AA10-2070ED2EC988Q33886452-FBAC7D03-A3BA-47EF-B6C8-180182FF5856Q33975703-2BB04D12-EC37-4253-A11B-23CECC5D6674Q34000001-8E25B130-E5F3-40A0-A6C8-D0E5DBC7D04AQ34520887-5714629F-A1B8-47D2-9393-5DAAE862DCCBQ35805230-174C0196-3FC5-487A-AF37-6D9C87C64B50Q36483809-44412343-EB8D-4A3B-B095-7E4098060B9CQ36694952-3DC6AE8E-2BD8-42AE-9B53-B48D7B3BEB49Q37039194-346E91B9-ED51-451C-85D2-D379F3A4D3EEQ37120327-C0FA14A7-D531-4009-A75D-DD1E2514905FQ37374457-7F20540E-6ED5-45E3-BB0A-A8B20429C4F4Q37513550-EA22991F-3A87-4986-8B72-CCEF6504B5DAQ39672052-E3327C72-EED7-4422-9E5C-070E347F6D7CQ40161808-37BEAB99-9E35-4CC1-8E4F-6D1F82924C2BQ45887549-F6C6A5AF-788B-4220-9799-DAB518241B67
P2860
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Novel vaccine approaches.
@en
type
label
Novel vaccine approaches.
@en
prefLabel
Novel vaccine approaches.
@en
P1476
Novel vaccine approaches.
@en
P304
P407
P577
1996-05-01T00:00:00Z